Bruker Corp (BRKR)
72.36
-0.16
(-0.22%)
USD |
NASDAQ |
May 07, 11:54
Bruker Price to Book Value: 7.339 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 7.356 |
| May 03, 2024 | 7.104 |
| May 02, 2024 | 7.109 |
| May 01, 2024 | 8.016 |
| April 30, 2024 | 7.912 |
| April 29, 2024 | 8.242 |
| April 26, 2024 | 8.212 |
| April 25, 2024 | 8.174 |
| April 24, 2024 | 8.337 |
| April 23, 2024 | 8.364 |
| April 22, 2024 | 7.916 |
| April 19, 2024 | 7.887 |
| April 18, 2024 | 7.968 |
| April 17, 2024 | 8.412 |
| April 16, 2024 | 8.509 |
| April 15, 2024 | 8.697 |
| April 12, 2024 | 8.883 |
| April 11, 2024 | 9.157 |
| April 10, 2024 | 8.979 |
| April 09, 2024 | 9.130 |
| April 08, 2024 | 9.152 |
| April 05, 2024 | 9.171 |
| April 04, 2024 | 9.105 |
| April 03, 2024 | 9.230 |
| April 02, 2024 | 9.221 |
| Date | Value |
|---|---|
| April 01, 2024 | 9.426 |
| March 31, 2024 | |
| March 28, 2024 | 9.391 |
| March 27, 2024 | 9.383 |
| March 26, 2024 | 9.237 |
| March 25, 2024 | 9.304 |
| March 22, 2024 | 9.387 |
| March 21, 2024 | 9.424 |
| March 20, 2024 | 9.294 |
| March 19, 2024 | 9.197 |
| March 18, 2024 | 9.199 |
| March 15, 2024 | 9.207 |
| March 14, 2024 | 9.180 |
| March 13, 2024 | 9.257 |
| March 12, 2024 | 9.269 |
| March 11, 2024 | 9.153 |
| March 08, 2024 | 9.113 |
| March 07, 2024 | 9.216 |
| March 06, 2024 | 9.050 |
| March 05, 2024 | 9.014 |
| March 04, 2024 | 9.002 |
| March 01, 2024 | 8.830 |
| February 29, 2024 | 8.651 |
| February 28, 2024 | 8.645 |
| February 27, 2024 | 8.367 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.316
Minimum
Apr 01 2020
13.77
Maximum
Sep 03 2021
8.937
Average
8.906
Median
Price to Book Value Benchmarks
| Azenta Inc | 1.261 |
| Harvard Bioscience Inc | 2.334 |
| Bionano Genomics Inc | 0.6919 |
| Akoya Biosciences Inc | 3.793 |
| Singular Genomics Systems Inc | 0.1792 |
Price to Book Value Related Metrics
| PE Ratio | 26.31 |
| PS Ratio | 3.540 |
| PEG Ratio | 0.8501 |
| Price to Free Cash Flow | 58.66 |
| Price | 72.36 |
| Earnings Yield | 3.80% |
| Market Cap | 10.52B |
| PEGY Ratio | 0.8426 |
| Operating PE Ratio | 24.61 |
| Normalized PE Ratio | 32.29 |